Drug-induced liver injury (DILI) is the most common cause of safety-related drug marketing withdrawals. We will briefly summarize the Food & Drug Administration’s DILI Guidance and illustrate how JMP Clinical can uncover cases of DILI using Hy’s Law.

Register now for this free Webinar.

*
*
*
*
  Please subscribe me to JMP Newswire, the monthly newsletter for JMP users.
  Yes, you may send me emails occasionally about JMP products and services. I understand that I can withdraw my consent at any time by clicking the opt-out link in the emails.

JMP is a division of SAS Institute Inc. and your information will be handled in accordance with the SAS Privacy Statement.

 
 

Back to Top